A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: A|DRUG: B|DRUG: CL1|DRUG: CL2|DRUG: CLH1|DRUG: CLH2|DRUG: CH1|DRUG: CH2|DRUG: CT1
Sponsor: Fudan University